Effect of aminoguanidine and copper(II) ions on the formation of advanced glycosylation end products: In vitro study on human serum albumin

Arzneimittel-Forschung/Drug Research

Volumn 51, Issue 4, 2001, Pages 280-283

  Jakus V ^a   Bauerova K ^a   Rietbrock, N ^a  

^a INSTITUTE OF CHEMISTRY   (Slovakia)

Author keywords

Albumin, human serum; Aminoguanidine; Copper(II) ions; Nonenzymatic glycosylation, end products, glycoxidation

Indexed keywords

ADVANCED GLYCATION END PRODUCT; AMINOGUANIDINE; COPPER CHLORIDE; COPPER ION; GLUCOSE; HUMAN SERUM ALBUMIN; PHOSPHATE; PIMAGIDINE;

ARTICLE; DIABETES MELLITUS; DRUG MECHANISM; HYPERGLYCEMIA; PROTEIN DEGRADATION; PROTEIN GLYCOSYLATION; SPECTROFLUOROMETRY;

EID: 0035034888     PISSN: 00044172     EISSN: None     Source Type: Journal    
DOI: 10.1055/s-0031-1300038     Document Type: Article

References (23)

1. Role of the Malllard reaction in diabetes mellitus and diseases of aging
2. Importance and possibilities of quantitation of advanced glycation end-products
3. Intermediate and final product of nonenzymatic glycation
4. Oxidative alterations in the experimental glycation model of diabetes mellitus are due to protein-glucose adduct oxidation. Some fundamental differences in proposed mechanisms of glucose oxidation and oxidant production
5. The pyridoindole antioxidant stobadine inhibited glycation-induced absorbance and fluorescence changes in albumin
6. Glucose modification of human serum albumin: A structural study
7. Effect of pH, phosphate and copper on the interaction of glucose with albumin
8. The role of metal catalyzed oxidation in the formation of advanced glycation end products: An in vitro study on collagen
9. An in vitro study on the role of metal catalyzed oxidation in glycation and crosslinking of collagen
10. Advanced glycosylated end products and hyperglycemia in the pathogenesis of diabetic complications
11. Inhibition of nonenzymatic protein glycation and lipid peroxidation by drugs with antioxidant activity
12. Antioxidant properties of aminoguanidine
13. Lack of reflect of copper on advanced Maillard reaction and glucose autoxidation at physiological concentrations of albumin
14. Oxidative glycation and free radical production: A causal mechanism of diabetic complications
15. Superoxide free radical generation by Amadori compounds: The role of acyclic forms and metal ions
16. Protein glycation and oxidative stress in diabetes mellitus and ageing
17. Glucose and free radicals impair the antioxidant properties of human serum albumin
18. Transition metals bind to glycated proteins forming redox active "glycochelates": Implications for the pathogenesis of certain diabetic complications
19. Protein aging by carboxymethylation of lysines generates sites by divalent metal and redox active copper binding: Relevance to diseases of glycoxidative stress
20. Chronic dosing with aminoguanidine and novel advanced glycosylation end product-formation inhibitors ameliorates cross-linking of tail tendon collagen in STZ-induced diabetic rats
21. Aminoguanidine and its pro-oxidant effects on an experimental model of protein glycation